Next stop, Mars

Jay Buckey describes well the three chief biomedical problems facing manned missions to Mars.1 Although I find his discussion of the radiation problem too pessimistic, we do need to think carefully about mission design and engineering in overcoming it.Above all, one needs to shorten the transit time to Mars and therefore study the trade-offs between the cost of extra propulsion versus the obvious gains (from reducing exposure to radiation and zero-G, as well as reducing the complexity and weight

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Jay Buckey describes well the three chief biomedical problems facing manned missions to Mars.1 Although I find his discussion of the radiation problem too pessimistic, we do need to think carefully about mission design and engineering in overcoming it.

Above all, one needs to shorten the transit time to Mars and therefore study the trade-offs between the cost of extra propulsion versus the obvious gains (from reducing exposure to radiation and zero-G, as well as reducing the complexity and weight of life support). For example, with additional propulsion between Earth and Mars instead of just coasting, the "Speedboat" mission2 would shorten the transit time to 100 days in each direction and permit a stay at or near Mars of 30 days. The total mission duration of less than eight months is well within the time frame of experience with the MIR and ISS space stations.

In-transit shielding against radiation is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • S Fred Singer

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio